174 218

Cited 0 times in

비만형 2형 당뇨병 환아에서 Metformin의 효과

Other Titles
 The Effect of Metformin in Obese Pediatric Patients with Type 2 Diabetes 
Authors
 정현희  ;  김덕희  ;  김태형 
Citation
 Journal of Korean Society of Pediatric Endocrinology (대한소아내분비학회지), Vol.12(2) : 127-134, 2007 
Journal Title
Journal of Korean Society of Pediatric Endocrinology(대한소아내분비학회지)
ISSN
 1226-2242 
Issue Date
2007
Keywords
Obesity ; Bodymassindex ; Glycemiccontrol ; Metformin
Abstract
Purpose Metformin is well-established oral hypoglycemic agent for adults and children with type 2 diabetes mellitus. In adults, metformin is effective as initial monotherapy with lack of weight gain. But, its beneficial role on obesity in children is less clearly defined. We assessed the effects of metformin in obese children with type 2 diabetes. Methods We evaluated body weight, height, body mass index, fasting blood sugar, HbA1c, lipid profiles in obese 36 children with type 2 diabetes treated with oral hypoglycemic agents at baseline, after 1 year and 2 years of treatment. We divided the subjects into three groups: metformin monotherapy, combination metformin with sulfonylurea, sulfonylurea monotherapy. The changes from baseline in three groups were measured. Results The decrease in body mass index, blood sugar & HbA1c was observed after treatment with metformin monotherapy group. Metformin monotherapy group after 1 & 2 years of treatment had a greater effect for body mass index (-1.9±1.7 kg/m2, -1.5±1.6 kg/m2,P<0.05). Conclusion The Metformin monotherapy for obese children with type 2 diabetes improves glycemic control with benefits of significant improvement in body mass index.
Files in This Item:
T200701534.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Duk Hee(김덕희)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/96450
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links